<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did Gossamer Bio's revenue surge in Q2 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 10:13pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Gossamer Bio's revenue surge in Q2 2024 was not driven by an increase in sales, rather it was due to **revenue recognition** from the sale of seralutinib in the US.

The company's total revenue (MRQ) for Q2 2024 was $9.38 million, with the latest report period ending on December 31, 2024. The revenue surprise as of June 30, 2024, was -18.45 million, which indicates a significant decrease in revenue compared to the previous quarter. This decline suggests that the revenue surge in Q2 2024 was not driven by an increase in sales, but rather by a one-time revenue recognition event related to the sale of seralutinib in the US.


</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar){return {layout:"default",data:[{noData:c,currentQuestion:f,textDescription:J,comeFrom:"AInvestShareLink",events:[],answerSource:r}],fetch:{},error:s,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:k,agent_id:a,output_media_info:[],task_id:a,language:a,source:r,cache_builder:a,reply_action:"Answer",execute_mode:C,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did Gossamer Bio's revenue surge in Q2 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did Gossamer Bio's revenue surge in Q2 2024?\",\"user_id\":\"dp33918482\",\"user_name\":\"\",\"trace_id\":\"76549ae5-cc6f-4fdf-963d-a4a5004a8b71\",\"session_id\":\"76549ae5-cc6f-4fdf-963d-a4a5004a8b71\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:K,query_type:o,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue (MRQ)|Latest Report Period|Latest Report End Date|Revenue Surprise[20240630]|Report End Date|\n|---|---|---|---|---|---|---|---|---|\n|GOSS|Gossamer Bio|$1.08|-1.83%|$9.38 million|2024Q4|20241231|-18.45 million|20240630|\n",query_data:{number:L,title:D,query_type:o,condition:a,model_sql:M,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:e}}},{info_type:K,query_type:o,text:"1 results found:\n|stock code|Latest Report Period|\n|---|---|\n|GOSS|2024Q4|\n",query_data:{number:k,title:y,query_type:o,condition:a,model_sql:N,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:e}}}],answer_chain_name:O,agent_mode:P,native_answer:a,come_from:a,text_answer:J,trace_id:l,cost:25279,event_names:a,question:f,fallback_type:Q,input_type:R,fall_back_reason:{fall_back_type:Q,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:l,first_return_cost:4581,cache_type:"no_cache",question_id:l,transfer_question:f,signal_type:"ON_COMPLETE",start_time:E,remote_svc:r,slots:[],answer_type:C,user_id:z,skill_name:F},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:l,session_id:l,user_id:z,question:f,source:r,raw_question:f,version:"3.4.1",action_name:F,nlu:{entity:[{type:S,value:"GOSS.O",market:T}]},output_time:E,deep_research:c,deep_thinking:c,agent_mode:P},extra:{}},{answer_path:g,section:{id:h,info_texts:["Thinking"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:g,section:{id:h,info_texts:[U],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:t},logs:[],extra:{action:A,action_input:y,thought:"The user wants to analyze why Gossamer Bio's revenue increased significantly in Q2 2024. I should focus on the latest report period to determine if the revenue increase was due to a seasonal factor. Additionally, I should analyze the latest earnings report, consider analyst opinions, and investigate why its revenue were growing. I will use FinQuery to obtain and identify the latest report period. Then, based on the identified quarter, I will use FinQuery for the revenue data and reasons; use Search for the earnings report, analyst opinions, and reasons for revenue growth."}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:g,section:{id:h,info_texts:[U],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:t},logs:[],extra:{action:A,action_input:y,thought:"Since Gossamer Bio's latest report period is 2024Q4, it is not the revenue surge occurred in Q2 2024. Therefore, I will use FinQuery to obtain and identify the latest report period again."}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:g,section:{id:h,info_texts:["Searching Web: Why Did Gossamer Bio's Revenue Grow in Q2 2024"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:t},logs:[],extra:{action:"Searching Web",action_input:"Why Did Gossamer Bio's Revenue Grow in Q2 2024",thought:G}},{answer_path:g,section:{id:h,info_texts:["Querying Stock: GOSS Revenue, Revenue Surprise in Q2 2024"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:t},logs:[],extra:{action:A,action_input:D,thought:G}},{answer_path:g,section:{id:h,info_texts:["Querying Stock: GOSS Analyst Consensus Rating, Analyst Average Price Target"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:t},logs:[],extra:{action:A,action_input:"GOSS Analyst Consensus Rating, Analyst Average Price Target",thought:G}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:g,section:{id:h,info_texts:["Generating Answer"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:n,voice_txt:"G",text_answer:V,rich_text:V,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:W,info_texts:[],show_type:n,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:D,query_type:o,trace_data:a,index:L,model_sql:M,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:e},jump_type:X}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:n,voice_txt:".\n\nThe",text_answer:Y,rich_text:Y,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"GOSS",market_id:T,name:Z,domain:S},pos:e,section_id:p,txt:Z,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:n,voice_txt:" total",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:W,info_texts:[],show_type:n,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:y,query_type:o,trace_data:a,index:k,model_sql:N,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:e},jump_type:X}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:n,voice_txt:". The",text_answer:$,rich_text:$,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:n,voice_txt:"\n",text_answer:aa,rich_text:aa,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:g,section:{id:h,info_texts:["Completed"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:u,query_text:u,trace_info:{item_id:"23e8fd2a9402b1410e6e4424caf2d3e3",item_type:q,item_name:u,rec_info:ab}},{display_text:v,query_text:v,trace_info:{item_id:"285d9ff6acb2d980c6315488dd7c2971",item_type:q,item_name:v,rec_info:ac}},{display_text:w,query_text:w,trace_info:{item_id:"2981dd62f2afea12f8ad9b0c3e51345a",item_type:q,item_name:w,rec_info:ad}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:ae,related_name:af}],puuid:H,tag:a,category:"custom",uuid:ag}],global:{urp_static_data:[{name:af,value:{status_code:e,columns:[{type:x,index_name:ah,key:ah},{type:x,index_name:ai,key:ai},{type:x,index_name:aj,key:aj},{type:x,index_name:ak,key:ak},{type:x,index_name:al,key:al}],datas:[{send_text:u,item_type:q,rec_info:ab,display_text:u,rec_reason:a},{send_text:v,item_type:q,rec_info:ac,display_text:v,rec_reason:a},{send_text:w,item_type:q,rec_info:ad,display_text:w,rec_reason:a}],dataSize:ae,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:am,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:B,"min-height":"100%",position:an,height:B},isMaterial:c,id:am,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:I,componentUuid:ag,script:[{name:ao,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:I,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:I},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:B,position:an,height:B},isMaterial:b,_id:19,id:ao,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ap,voice_txt:a,tracking_info:{},uuid:H},order:{is_auto:c,render_for:ap,chart_type:"command",puuid:H}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:F,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:C,answer_chain_name:O},is_deep_research:c,deep_thinking:c,create_time:1746713657097},is_last:b}],questionItem:{data:{qStr:f,encodeFlag:c,imageData:s,docsData:[],quoteData:s},tplType:"question"},events:aq,agentId:a,param:{entity_info:{},add_info:{ori_question:f},event_list:aq,client_ip:a,question:f,user_id:z,user_name:a,trace_id:l,session_id:l,source:r,input_type:R}}],userId:z,userName:a,startTime:E,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:s,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:s,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-gossamer-bios-revenue-surge-in-q2-2024-61c486\u002F",config:{_app:{basePath:ar,assetsPath:ar,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"How did Gossamer Bio's revenue surge in Q2 2024?","progress\u002Fsearching_for",1000,"searching_for","signal",1,"76549ae5-cc6f-4fdf-963d-a4a5004a8b71",999,"rich_text","intusstock",2001,"llm_generated","ths_ainvest_lite_web",null,"thinking","📊 What is the current market sentiment towards Gossamer Bio's stock?","🩺 Are there any recent clinical trial results that could have contributed to Gossamer Bio's revenue growth?","📈 How did Gossamer Bio's operating expenses change in Q2 2024 compared to previous quarters?","STR","GOSS Latest Report Period","dp33918482","Querying Stock","auto","agent","GOSS Revenue, Revenue Surprise in Q2 2024",1746713631819,"explain news events","I have obtained enough information. Gossamer Bio's revenue surge in Q2 2024 was not driven by a seasonal factor. I should use Search to find the reasons about why its revenue were growing in Q2 2024, and use FinQuery to obtain the corresponding financial data and analyst opinions.","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Gossamer Bio's revenue surge in Q2 2024 was not driven by an increase in sales, rather it was due to **revenue recognition** from the sale of seralutinib in the US.\n\nThe company's total revenue (MRQ) for Q2 2024 was $9.38 million, with the latest report period ending on December 31, 2024. The revenue surprise as of June 30, 2024, was -18.45 million, which indicates a significant decrease in revenue compared to the previous quarter. This decline suggests that the revenue surge in Q2 2024 was not driven by an increase in sales, but rather by a one-time revenue recognition event related to the sale of seralutinib in the US.\n\n\n","query_data",7,"select   stock_code,   total_revenue from   ustock_fin_data where   stock_code = 'GOSS.O' intersect select   stock_code,   revenue_surprise from   ustock_fin_forecast where   report_end_date = date('2024y2q')   and stock_code = 'GOSS.O'","select   stock_code,   report_period from   ustock_fin_data where   report_end_date = date('latest')   and stock_code = 'GOSS.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","185","Querying Stock: GOSS Latest Report Period","Gossamer Bio's revenue surge in Q2 2024 was not driven by an increase in sales, rather it was due to **revenue recognition** from the sale of seralutinib in the US[^7]",2000,"data_query",".\n\nThe company's","Gossamer Bio"," total revenue (MRQ) for Q2 2024 was $9.38 million, with the latest report period ending on December 31, 2024[^1]",". The revenue surprise as of June 30, 2024, was -18.45 million, which indicates a significant decrease in revenue compared to the previous quarter[^7]. This decline suggests that the revenue surge in Q2 2024 was not driven by an increase in sales, but rather by a one-time revenue recognition event related to the sale of seralutinib in the US.\n\n","\n``` visual\n{\"uuid\":\"d45f8b10-9b1e-4923-8319-ee139c3764a7\"}\n```","2+679_496_21_554+0+0+76549ae5-cc6f-4fdf-963d-a4a5004a8b71+23e8fd2a9402b1410e6e4424caf2d3e3+llm_generated+aimeTagAnalysis+0+0.004664659965783358+1","2+679_496_21_554+0+0+76549ae5-cc6f-4fdf-963d-a4a5004a8b71+285d9ff6acb2d980c6315488dd7c2971+llm_generated+aimeTagAnalysis+0+0.003108993638306856+2","2+679_496_21_554+0+0+76549ae5-cc6f-4fdf-963d-a4a5004a8b71+2981dd62f2afea12f8ad9b0c3e51345a+llm_generated+aimeTagAnalysis+0+0.0027316929772496223+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>